2012 trivalent influenza vaccine

The 2012 trivalent influenza vaccine is a seasonal vaccine designed to provide protection against three specific influenza virus strains (two influenza A subtypes and one influenza B subtype) that were predicted to be most prevalent during the 2012-2013 influenza season. Its mechanism of action involves introducing inactivated or attenuated viral antigens to the body, stimulating the immune system to produce antibodies and T-cells, thereby conferring immunity against future infection by these specific strains. This vaccine is a pharmaceutical drug administered annually to prevent seasonal influenza.

Brand names

AfluriaFluarixFluLavalFluMistFluvirinFluzoneFluzone High-DoseFluzone Intradermal

Other names

TIV